David Matthew Furfaro, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Endarterectomy | 1 | 2022 | 196 | 0.790 |
Why?
|
Extracorporeal Membrane Oxygenation | 4 | 2024 | 1462 | 0.660 |
Why?
|
Catheterization, Swan-Ganz | 1 | 2018 | 86 | 0.580 |
Why?
|
Lung Transplantation | 2 | 2024 | 1310 | 0.510 |
Why?
|
Pulmonary Embolism | 2 | 2019 | 2567 | 0.480 |
Why?
|
Dyspnea | 1 | 2022 | 1347 | 0.470 |
Why?
|
Lung Diseases, Interstitial | 2 | 2024 | 918 | 0.440 |
Why?
|
Hypertension, Pulmonary | 2 | 2024 | 1578 | 0.400 |
Why?
|
Education, Medical | 1 | 2024 | 1725 | 0.400 |
Why?
|
Cystic Fibrosis | 1 | 2021 | 1285 | 0.400 |
Why?
|
Healthcare Disparities | 2 | 2024 | 3358 | 0.330 |
Why?
|
Artificial Intelligence | 1 | 2024 | 2578 | 0.330 |
Why?
|
Thrombolytic Therapy | 1 | 2018 | 2064 | 0.320 |
Why?
|
Waiting Lists | 2 | 2024 | 765 | 0.300 |
Why?
|
Mitral Valve Insufficiency | 1 | 2016 | 1400 | 0.270 |
Why?
|
Diagnostic Imaging | 1 | 2019 | 3530 | 0.240 |
Why?
|
Patient Selection | 2 | 2024 | 4244 | 0.180 |
Why?
|
Liver Failure, Acute | 1 | 2021 | 181 | 0.170 |
Why?
|
Catheterization | 1 | 2024 | 1428 | 0.160 |
Why?
|
Zollinger-Ellison Syndrome | 1 | 2018 | 13 | 0.150 |
Why?
|
Gastrinoma | 1 | 2018 | 20 | 0.150 |
Why?
|
Clozapine | 1 | 2021 | 504 | 0.150 |
Why?
|
Hematology | 1 | 2021 | 243 | 0.150 |
Why?
|
Education, Distance | 1 | 2021 | 261 | 0.150 |
Why?
|
Tissue and Organ Procurement | 2 | 2024 | 962 | 0.140 |
Why?
|
Neoplasms, Unknown Primary | 1 | 2018 | 101 | 0.140 |
Why?
|
Chest Pain | 1 | 2022 | 1091 | 0.130 |
Why?
|
End Stage Liver Disease | 1 | 2018 | 352 | 0.110 |
Why?
|
Survivors | 1 | 2024 | 2371 | 0.110 |
Why?
|
Buprenorphine | 1 | 2021 | 656 | 0.110 |
Why?
|
Adrenal Cortex Hormones | 1 | 2021 | 1881 | 0.100 |
Why?
|
Middle Aged | 11 | 2024 | 220921 | 0.100 |
Why?
|
Diarrhea | 1 | 2018 | 1318 | 0.090 |
Why?
|
Registries | 1 | 2024 | 8225 | 0.080 |
Why?
|
Academic Medical Centers | 1 | 2019 | 2759 | 0.080 |
Why?
|
Humans | 18 | 2024 | 761596 | 0.080 |
Why?
|
Wakefulness | 2 | 2024 | 1265 | 0.070 |
Why?
|
Anticoagulants | 1 | 2022 | 4812 | 0.070 |
Why?
|
Chronic Disease | 2 | 2019 | 9319 | 0.070 |
Why?
|
Liver Transplantation | 1 | 2018 | 2330 | 0.070 |
Why?
|
Health Services Accessibility | 1 | 2024 | 5440 | 0.070 |
Why?
|
Sepsis | 1 | 2020 | 2585 | 0.070 |
Why?
|
Opioid-Related Disorders | 1 | 2021 | 2164 | 0.070 |
Why?
|
Male | 10 | 2024 | 360846 | 0.060 |
Why?
|
Heart Diseases | 1 | 2018 | 2781 | 0.060 |
Why?
|
Hospitalization | 1 | 2024 | 10721 | 0.060 |
Why?
|
Female | 10 | 2024 | 392705 | 0.060 |
Why?
|
Adult | 7 | 2024 | 221210 | 0.060 |
Why?
|
Aged | 8 | 2024 | 169310 | 0.050 |
Why?
|
Liver | 1 | 2018 | 7528 | 0.050 |
Why?
|
Liver Neoplasms | 1 | 2018 | 4317 | 0.050 |
Why?
|
New York City | 1 | 2024 | 731 | 0.050 |
Why?
|
Retrospective Studies | 4 | 2024 | 80647 | 0.040 |
Why?
|
Acetylcysteine | 1 | 2021 | 260 | 0.040 |
Why?
|
Videoconferencing | 1 | 2021 | 203 | 0.040 |
Why?
|
Prognosis | 1 | 2018 | 29629 | 0.040 |
Why?
|
Propensity Score | 1 | 2024 | 1913 | 0.030 |
Why?
|
Polycythemia | 1 | 2018 | 124 | 0.030 |
Why?
|
Opiate Substitution Treatment | 1 | 2021 | 444 | 0.030 |
Why?
|
Risk Assessment | 1 | 2018 | 23996 | 0.030 |
Why?
|
Blood Chemical Analysis | 1 | 2018 | 437 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2018 | 15633 | 0.030 |
Why?
|
Prospective Studies | 3 | 2024 | 54423 | 0.030 |
Why?
|
Patients | 1 | 2021 | 907 | 0.030 |
Why?
|
Interleukin-6 | 1 | 2023 | 3208 | 0.030 |
Why?
|
Respiration, Artificial | 1 | 2023 | 2630 | 0.020 |
Why?
|
Abdomen | 1 | 2018 | 1128 | 0.020 |
Why?
|
Abdominal Pain | 1 | 2018 | 1071 | 0.020 |
Why?
|
Treatment Outcome | 1 | 2018 | 64685 | 0.020 |
Why?
|
Hospital Mortality | 1 | 2024 | 5293 | 0.020 |
Why?
|
Critical Illness | 1 | 2023 | 2723 | 0.020 |
Why?
|
Decision Making | 1 | 2024 | 3929 | 0.020 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2024 | 3204 | 0.020 |
Why?
|
Inpatients | 1 | 2020 | 2548 | 0.020 |
Why?
|
Patient Discharge | 1 | 2021 | 3443 | 0.020 |
Why?
|
Cohort Studies | 2 | 2021 | 41495 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2020 | 3744 | 0.020 |
Why?
|
Cross-Sectional Studies | 1 | 2024 | 26129 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2018 | 12973 | 0.010 |
Why?
|
Medicare | 1 | 2020 | 6770 | 0.010 |
Why?
|
Time Factors | 1 | 2018 | 39969 | 0.010 |
Why?
|
United States | 1 | 2020 | 72340 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2018 | 36426 | 0.010 |
Why?
|